Trial Details

UNKNOWN
Basic Information
Clinical ID c1391
Identifier NCT05113888
Trial Title Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Qizhi weitong granules(High)|DRUG: Qizhi weitong granules(Low)|DRUG: Placebo
Participant Information
Sponsor China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-12-01
Primary Completion Date 2022-08-31
Completion Date 2022-12-31